TechConnect Innovation Program

Blood Test for Early Detection of Cancer and Autoimmune Diseases

Nano Discovery Inc., FL, United States

TECHNOLOGY SUMMARY

We have developed a nanotechnology-enabled blood test for early detection and diagnosis of cancer and autoimmune diseases.

Primary Application Area: Medical Devices

Technology Development Status: Proven Manufacturability

Technology Readiness Level: TRL 7

FIGURES OF MERIT

Value Proposition: Non-invasive screening tests for early stage cancer detection and screening are almost non-existent for most cancer types. Many autoimmune conditions are not detected until they reached more debilitating advanced stages. Our test can potentially detect cancer and autoimmune conditions months even years before clinical diagnosis and symptoms to appear.

SHOWCASE SUMMARY

Organization Type: Early-stage Startup (Seed)

National Innovation Awardee

Showcase Booth #: 52M

Website: www.nanodiscoveryinc.com

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date: Florida Department of Health Bankhead-Coley Foundation, $100,000

State of Florida SURCAG grant through University of Central Florida, $75,000

Primary Sources of Funding: Angel, Friends, Family

Looking for: Development / License Partners